Home » Topics » Regulatory » Patents

Patents
RSS

Janssen Pharmaceutica discloses new antifungal agents

Dec. 5, 2012

Wellstat Immuno Therapeutics prepares new polypeptides

Dec. 5, 2012

New bromodomain-containing protein inhibitors disclosed by GlaxoSmithKline

Dec. 4, 2012

Merck & Co. prepares new agents for hypertension

Dec. 4, 2012

New Zealand and U.S. researchers present new antimalarial agents

Dec. 4, 2012

FORMA Therapeutics divulges novel NAmPRTase inhibitors

Dec. 4, 2012

Roche patents new glucokinase activators for diabetes

Dec. 4, 2012

New diagnostic agents for cancer designed by Bayer Schering Pharma

Dec. 4, 2012

New vaccines for dengue virus presented by Merck & Co.

Dec. 4, 2012

University of Sydney discloses novel agents isolated from propolis

Dec. 3, 2012

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...